News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Delphi Genetics Grants GlaxoSmithKline (GSK) a Licence for the Use of the StabyExpress System


9/22/2010 9:27:57 AM

CHARLEROI, Belgium--(BUSINESS WIRE)--Delphi Genetics SA (“Delphi”) has announced today the signature of a licensing agreement with GlaxoSmithKline (GSK) for the use of the patented StabyExpress technology for the production of protein vaccines for human use.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES